Drawing for CELLEGY PHARMACEUTICALS

USPTO serial 75867103

CELLEGY PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 2879790Status 710
Filing date
Status date
Registration date
Aug 31, 2004
Examiner
WILLIS, PAMELA Y
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CELLEGY PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Priscilla Mark

PRISCILLA MARK HELLER EHRMAN WHITE & MCAULIFFE LLP275 MIDDLEFIELD RDMENLO PARK, CA 94025-3506UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Skin creams, gels, ointments, lotions, masks, moisturizers, anti-wrinkle and anti-aging preparationsSECTION 8 - CANCELLEDApr 23, 2004
005Medicated skin care preparations; medicated skin creams, gels, ointments, lotions, masks; dermatologicals; anti-inflammatories; anti-irritants; anti-allergenics; pharmaceutical compounds for topical use for the treatment of skin and mucous membrane diseases; pharmaceutical preparations, namely topical penetration enhancers for drug delivery through the skin and mucous membranes; transdermal gel for hormone therapy; testosterone gel; and hormone preparations for use in the treatment of hypogonadismSECTION 8 - CANCELLEDApr 23, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 1, 2011C8..CANCELLED SEC. 8 (6-YR)—
Aug 31, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 18, 2004CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 17, 2004DOCKASSIGNED TO EXAMINER—
May 13, 2004SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 5, 2004CFITCASE FILE IN TICRS—
Apr 30, 2004IUAFUSE AMENDMENT FILED—
Apr 30, 2004EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 21, 2003EX5GSOU EXTENSION 5 GRANTED—
Oct 21, 2003EXT5SOU EXTENSION 5 FILED—
Oct 21, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 1, 2003EX4GSOU EXTENSION 4 GRANTED—
Apr 24, 2003EXT4SOU EXTENSION 4 FILED—
Apr 24, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2003EX3GSOU EXTENSION 3 GRANTED—
Nov 8, 2002EXT3SOU EXTENSION 3 FILED—
Nov 8, 2002MAILPAPER RECEIVED—
May 30, 2002EX2GSOU EXTENSION 2 GRANTED—
May 13, 2002MAILPAPER RECEIVED—
May 9, 2002EXT2SOU EXTENSION 2 FILED—
Nov 8, 2001EX1GSOU EXTENSION 1 GRANTED—
Oct 24, 2001EXT1SOU EXTENSION 1 FILED—
May 15, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2001OP.TOPPOSITION TERMINATED NO. 999999—
Mar 21, 2001OP.DOPPOSITION DISMISSED NO. 999999—
Dec 12, 2000OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 6, 2000ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 8, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 7, 2000NPUBNOTICE OF PUBLICATION—
Jun 6, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2000CNEAEXAMINER'S AMENDMENT MAILED—
May 19, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance